Picture of Steris logo

STE Steris Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Steris, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

R2019
March 31st
R2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,7823,0313,1084,5854,958
Cost of Revenue
Gross Profit1,1751,3201,3432,0162,160
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses2,3712,4942,5594,1594,690
Operating Profit411537548426268
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes369499518315157
Provision for Income Taxes
Net Income After Taxes305408397243106
Minority Interest
Net Income Before Extraordinary Items
Net Income304408397244107
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income304408397244107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4.564.935.184.734.61
Dividends per Share